Sumitomo Pharma Co., Ltd. (4506) Other
Market cap
¥877B
P/E ratio
9.5x
Sumitomo Pharma manufactures and sells prescription pharmaceuticals globally, with specialized focus on regenerative and cell medicine through joint ventures.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | 3.5 | 3.9 | 6.7 | 5.9 | 3.9 | 4.4 | 4.3 | -4.6 | -19.3 | 2.9 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 7,601 | 7,218 | 7,015 | 6,868 | 6,697 | 6,492 | 6,268 | 6,140 | 6,457 | 6,822 | 6,987 | 6,250 | 4,980 | 3,832 |